Search Results - "Rodriguez, Yoan E"
-
1
Capivasertib-Induced Diabetic Ketoacidosis in a Patient With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer and No Prior History of Diabetes Mellitus: A Case Report
Published in Curēus (Palo Alto, CA) (02-07-2024)“…Capivasertib, a pan-AKT inhibitor, has shown promising efficacy in treating metastatic tumors harboring the mutation. However, its use is associated with…”
Get full text
Journal Article -
2
Response of FGFR-2 Positive Adenoid Cystic Carcinoma to Futibatinib: A Case Report
Published in Curēus (Palo Alto, CA) (27-06-2024)“…Adenoid cystic carcinoma (ACC) is an uncommon and aggressive head and neck cancer mainly affecting minor salivary glands. It affects more women than men in…”
Get full text
Journal Article -
3
Hydralazine-Induced Antineutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis Presenting as Crescentic Glomerulonephritis
Published in Curēus (Palo Alto, CA) (26-04-2024)“…Hydralazine is a vasodilator medication commonly used for treating hypertension. While generally well-tolerated, in rare cases it can induce autoimmune…”
Get full text
Journal Article -
4
Creation of Formalin-Fixed, Paraffin-Embedded 3D Lung Cancer Cellular Spheroids for the Optimization of Immunohistochemistry Staining Procedures
Published in Methods in molecular biology (Clifton, N.J.) (2021)“…In an era of precision medicine important treatment decisions are dictated by expression of clinically informative tumor protein biomarkers. These biomarkers…”
Get more information
Journal Article -
5
Hydralazine-Induced Antineutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis Presenting as Crescentic Glomerulonephritis
Published in Cureus (01-04-2024)“…Hydralazine is a vasodilator medication commonly used for treating hypertension. While generally well-tolerated, in rare cases it can induce autoimmune…”
Get full text
Report